BHCM
Brevan Howard Capital Management’s Intellia Therapeutics NTLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $207K | Buy |
+22,097
| New | +$207K | ﹤0.01% | 1611 |
|
|
2025
Q1 | – | Sell |
-108,351
| Closed | -$1.26M | – | 1319 |
|
|
2024
Q4 | $1.26M | Buy |
108,351
+93,433
| +626% | +$1.09M | 0.01% | 345 |
|
|
2024
Q3 | $307K | Buy |
+14,918
| New | +$307K | ﹤0.01% | 794 |
|
|
2021
Q2 | – | Sell |
-36,788
| Closed | -$2.95M | – | 42 |
|
|
2021
Q1 | $2.95M | Sell |
36,788
-21,222
| -37% | -$1.7M | 0.43% | 11 |
|
|
2020
Q4 | $3.16M | Buy |
+58,010
| New | +$3.16M | 0.63% | 19 |
|